An Electronic Consultation Program Impacts on Heart Failure Patients' Prognosis: Implications for Heart Failure Care
Pilar Mazón‐Ramos(Universidade de Santiago de Compostela), José Ramón González‐Juanatey(Centro de Investigación en Red en Enfermedades Cardiovasculares), Manuel Portela‐Romero(Instituto de Investigación Sanitaria de Santiago), Pedro Rigueiro‐Veloso(Centro de Investigación en Red en Enfermedades Cardiovasculares), Belén Álvarez Álvarez(Centro de Investigación en Red en Enfermedades Cardiovasculares), Cristina Ameixeiras‐Cundins(Instituto de Investigación Sanitaria de Santiago), Ricardo Lage(Centro de Investigación en Red en Enfermedades Cardiovasculares), David García‐Vega(Complejo Hospitalario Universitario de Santiago), Daniel Rey‐Aldana(BirdLife Australia), Sergio Cinza‐Sanjurjo(Universidade de Santiago de Compostela)
Cited by 16
Related Papers
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
Periodontitis and cardiovascular diseases: Consensus report
|Journal Of Clinical Periodontology|2020|1.5k
Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registry
|European Heart Journal|2020|282
Periodontitis and Cardiovascular Diseases. Consensus Report
|Global Heart|2020|274
Patient Phenotype Profiling in Heart Failure with Preserved Ejection Fraction to Guide Therapeutic Decision Making. A Scientific Statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension
|European Journal of Heart Failure|2023|187